The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Flynn Karen since year 2005.
The trader's CIK number is 1553599.
At the time of this reporting, Flynn Karen is the Director of Recro Pharma, Inc. .
(stock ticker symbol REPH).
See this page for all insider trading activities at Recro Pharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-12-16||REPH||Recro Pharma, Inc.||Buy||800||6.71||5,364|
|2016-09-06||WST||West Pharmaceutical Services Inc||Sale||14,581||83.28||1,214,305|
|2015-11-10||WST||West Pharmaceutical Services Inc||Option Ex||18,020||20.88||376,311|
|2015-11-10||WST||West Pharmaceutical Services Inc||Sale||18,020||63.03||1,135,728|
|2015-05-22||WST||West Pharmaceutical Services Inc||Option Ex||3,091||16.05||49,595|
|2015-05-22||WST||West Pharmaceutical Services Inc||Sale||3,091||55.24||170,737|
|2015-05-18||WST||West Pharmaceutical Services Inc||Option Ex||1,909||16.05||30,629|
|2015-05-18||WST||West Pharmaceutical Services Inc||Sale||1,909||55.00||104,995|
|2013-11-19||WST||West Pharmaceutical Services Inc||Sale||5,500||47.75||262,625|
|2013-11-19||WST||West Pharmaceutical Services Inc||Option Ex||5,500||22.89||125,895|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flynn Karen (Director of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.